申请人:Bayly Christopher I.
公开号:US20090281103A1
公开(公告)日:2009-11-12
The present invention relates to novel renin inhibitors of the general Formula (I), and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds. These novel renin inhibitors are used in treating cardiovascular events and renal insufficiency.
本发明涉及一种新型肾素抑制剂,其通式为(I),并且它们作为制备制药组合物的活性成分使用。该发明还涉及相关方面,包括化合物的制备过程。这些新型肾素抑制剂用于治疗心血管事件和肾功能不全。